Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1 neutralizing activity.

/in
Song R, Oren DA, Franco D, Seaman MS, Ho DD. Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1 neutralizing activity. Nat. Biotechnol. 2013, 31(11):1047-52. [Article]